It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Oxidative stress in combination with acid stress has been shown to inactivate a wide spectrum of microorganisms, including multi-resistant bacteria. This occurs e.g. in phagolysosomes or during treatment by cold atmospheric pressure plasmas (CAP) and possibly depends on the cell membrane. We therefore explored the effects of CAP-generated reactive oxygen and nitrogen species (RONS) on bacterial growth inhibition and membranes in neutral and acidic suspensions. We observed that growth inhibition was most efficient when bacteria were treated by a mix of short and long-lived RONS in an acidic environment. Membrane packing was affected mainly upon contact with short-lived RONS, while also acidity strongly modulated packing. Under these conditions, Gram-negative bacteria displayed large potassium release while SYTOX Green influx remained marginal. Growth inhibition of Gram-negative bacteria correlated well with outer membrane (OM) permeabilization that occurred upon contact with short and/or long-lived RONS in synergy with acidity. In Gram-positive bacteria, CAP impaired membrane potential possibly through pore formation upon contact with short-lived RONS while formation of membrane protein hydroperoxides was probably involved in these effects. In summary, our study provides a wide perspective on understanding inactivation mechanisms of bacteria by RONS in combination with acidity.
Synergistic effects of oxidative and acid stress on a typical Gram-negative and Gram-positive bacterial membrane in the context of cold atmospheric pressure plasma treatment
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Utrecht University, Membrane Biochemistry & Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000 0000 9637 0671)
2 Utrecht University, Membrane Biochemistry & Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000 0000 9637 0671); Campusplein 1, University College Utrecht, Utrecht, The Netherlands (GRID:grid.5477.1)
3 Eindhoven University of Technology, Applied Physics Department, Eindhoven, The Netherlands (GRID:grid.6852.9) (ISNI:0000 0004 0398 8763)
4 University Medical Center Utrecht, Pathology Department, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000 0000 9012 6352)
5 Utrecht University, Membrane Biochemistry & Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000 0000 9637 0671); UCLouvain, Cellular and Molecular Pharmacology, Translational Research from Experimental and Clinical Pharmacology to Treatment Optimization, Louvain Drug Research Institute, Brussels, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X)